logo
Plus   Neg
Share
Email

GSK: FDA Approves ViiV Healthcare's Dovato - Quick Facts

GlaxoSmithKline plc (GSK.L,GSK) reported that ViiV Healthcare announced the US FDA approved Dovato, a once-daily, single-tablet regimen of dolutegravir (DTG) 50 mg and lamivudine (3TC) 300 mg for the treatment of HIV-1 infection in adults with no antiretroviral treatment history and with no known resistance to either DTG or 3TC.

DTG/3TC as a once-daily, single-tablet, two-drug regimen for HIV-1 therapy is currently under review by the European Medicines Agency and regulatory authorities in Canada, Australia, Switzerland, and South Africa and several additional submissions are planned throughout 2019.

ViiV Healthcare is a global specialist HIV company established in 2009 by GlaxoSmithKline and Pfizer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Crate and Barrel have recalled 1,500 push walkers due to risk of choking and laceration. Crate and Barrel have recalled Activity Push Walkers as those walkers can be damaged over time exposing sharp points and small parts, posing choking and laceration hazards to small children. The wooden recalled... YouTube is finalizing plans under which it will no longer serve "targeted" advertisements on its main site for videos meant for kids, Bloomberg reported, citing people familiar with the discussion. While the plan is reportedly intended to satisfy U.S. regulators, it could negatively impact the Google-owned video giant's ad sales as kids' content on YouTube is immensely popular. Apple Inc. (AAPL) is in the final stages of certifying advanced flexible Organic Light Emitting Diode or OLED screens from Chinese display maker BOE Technology Group for iPhones next year, the Nikkei Asian Review reported citing source. The U.S. tech giant has been attempting to reduce reliance on Samsung Electronics of South Korea.
Follow RTT